Related Experiment Videos
Disease management: definitions, difficulties and future directions.
A Pilnick1, R Dingwall, K Starkey
1Genetics and Society Unit, School of Sociology and Social Policy, University of Nottingham, England. Alison.Pilnick@nottingham.ac.uk
Bulletin of the World Health Organization
|September 8, 2001
Summary
Managed care and disease management programs in the USA show promise for healthcare reform. However, their exportability to other countries, like the UK, requires careful consideration of differing healthcare models.
Area of Science:
- Health Services Research
- Comparative Health Policy
Background:
- The USA has implemented managed care and disease management strategies to control healthcare costs and improve effectiveness.
- These US-based models are often suggested for international healthcare reform due to their perceived success.
Purpose of the Study:
- To evaluate the exportability of US managed care and disease management programs to other countries.
- To analyze the constituent elements of disease management and their implications for international healthcare systems.
Main Methods:
- Conceptual explanation of managed care and disease management.
- Contextualization of these programs within the US healthcare system.
- Stakeholder analysis from the UK perspective.
- Review of evaluations of disease management programs.
- Comparative analysis of US and UK healthcare models.
Main Results:
- Disease management involves specific, identifiable elements.
- Significant differences exist between the US and UK healthcare systems (National Health Service).
- Evaluations of disease management programs reveal notable weaknesses.
Conclusions:
- The direct exportability of US managed care and disease management models to other countries, such as the UK, is questionable due to systemic differences.
- Further discussion is needed regarding the prospects for disease management in Europe.